Success Story: EB-1A Petition Approved for a Research Investigator from China in the Field of Cardiovascular Diseases with the Proper Guidance and Support from NAILG’s Experts

Posted by wegreened on February 26, 2024 in EB1 Green Card, Medical (Gastroenterology, Cancer, Cancer Pharmacology, Cardiology, Immunology, Pathology, Hematology, Neurology, Neuroscience, Urology, Gynecology, Dentistry, Endocrinology)

Client’s Testimonial:

“Thank your team for the excellent work.”

On July 27^th, 2023, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Investigator in the Field of Cardiovascular Diseases (Approval Notice).

General Field: Cardiovascular Diseases

Position at the Time of Case Filing: Research Investigator

Country of Origin: China

State of Residence at the Time of Filing: Michigan

Approval Notice Date: July 27^th, 2023

Processing Time: 31 days (Premium Processing Requested)

Case Summary:

A research investigator in the field of cardiovascular diseases met us asking for help on her EB-1A (Alien of Extraordinary Ability) case. So, once we had assured her that we would do everything in our power to make this journey a smooth one for her, we moved to make a well-grounded background study and then began with the attorney-client formalities.

Our team of experts took over the case preparation and used all the information that we had on her academic and professional background. This meant using this data in her petition to build a strong case in her favor.

The personalized petition included her citation records, peer reviews, and publication count. The details of the same are mentioned below:

She has conducted at least 17 reviews for at least 6 prestigious journals.
Her work has resulted in 21 peer-reviewed scientific articles published in the top-ranked journals of her field of endeavor.
Her research has been cited 546 times in at least 35 countries according to Google Scholar.
She also served as an editorial board member for 2 journals and guest associate editor for 1 journal.

Furthermore, she received her Ph.D. in human physiology and her work has regularly inspired further advances in understanding the roles of endothelial cell dysfunction and smooth muscle cell plasticity in cardiovascular diseases, particularly those studies centered on the mechanisms involved in abdominal aortic aneurysm formation, including the specific roles of proteins and pathways in either inciting or protecting against aneurysm and other cardiovascular diseases.

Considering this widespread use of her work, it is clear that our client is a keystone researcher in the field of cardiovascular diseases.

Her work has thus been majorly significant, and her achievements are of the utmost importance due to their direct applicability in global efforts to address cardiovascular disease.

Furthermore, 4 leading researchers from top universities and research groups from the United States and abroad have submitted letters confirming her as an outstanding researcher in her specialized field.

We are certain that her work is dedicated to advances in cardiovascular diseases, which are matters of critical national importance. Experts agree that her continued participation is critical to the overall success of preventing and treating cardiovascular disease in the field of endeavor. Thanks to premium processing, she received her EB1-A approval in a shorter duration of time (31 days only).

We thus wish her the very best in her life and success in all the endeavors that she takes up soon.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%